Learn More Learn more “Greater pathogen detection for better decisions” Clinical Diagnostics Biologics Genomic Service What’s NewWatch the replay of our webinar – Accelerated vaccines development and production: in-process NGS QC testing for risk mitigations26 May 2020PathoQuest Announces Appointment of Laurent Lafferrere as Chief Operating Officer27 April 2020Watch the replay of our webinar – The Benefits of NGS-Based Quality Control for Routine Biologics testing using GLP-Certified Solutions14 April 2020Transgene chooses PathoQuest innovative NGS-based safety release test for TG4050 phase I clinical trial targeting patients with head-neck and ovarian cancers and for Invir.IO™ platform for recombinant viral vector manufacturing.20 February 2020
